언어 선택

IL-2 R alpha

IL-2 R alpha 분자 정보

영어 이름	Interleukin-2 receptor alpha chain	시판 약물 수	3
임상 약물 수	16	표적 별명	TAC antigen，p55，IL2-RA，Interleukin-2 receptor subunit alpha，IL-2-RA，IL-2R subunit alpha，IL2RA，Interleukin 2 Receptor Subunit Alpha，Interleukin 2 Receptor， Alpha，IL-2 Receptor Subunit Alpha，Insulin-Dependent Diabetes Mellitus 10，CD25 Antigen，IDDM10，IMD41，TCGFR，CD25，Interleukin-2 Receptor alpha Subunit，IL-2R alpha
최고 연구 개발 단계	Approved

영어 이름	Interleukin-2 receptor alpha chain
표적 별명	TAC antigen，p55，IL2-RA，Interleukin-2 receptor subunit alpha，IL-2-RA，IL-2R subunit alpha，IL2RA，Interleukin 2 Receptor Subunit Alpha，Interleukin 2 Receptor， Alpha，IL-2 Receptor Subunit Alpha，Insulin-Dependent Diabetes Mellitus 10，CD25 Antigen，IDDM10，IMD41，TCGFR，CD25，Interleukin-2 Receptor alpha Subunit，IL-2R alpha
시판 약물 수	3
임상 약물 수	16
최고 연구 개발 단계	Approved

IL-2 R alpha 제품 목록

속성
Protein (11)
제품 라이브러리
온라인 (11)
종
Human (4)Mouse (2)Canine (1)Cynomolgus (2)Rhesus macaque (1)Rat (1)
태그
Fc Tag (1)His Tag (6)His Tag & Avi Tag (3)Fc Tag & Avi Tag (1)
마커
Unconjugated (7)Biotin-labeled (4)

제품 번호	종	발현 시스템	제품 설명
HOT ILA-H5251	Human	HEK293	Human IL-2 R alpha / CD25 Protein, Fc Tag, low Endotoxin (MALS verified)
HOT ILA-H52H9	Human	HEK293	Human IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (MALS verified)
HOT ILA-H82E6	Human	HEK293	Biotinylated Human IL-2 R alpha / CD25 Protein, His,Avitag™, premium grade
HOT ILA-M52H9	Mouse	HEK293	Mouse IL-2 R alpha / CD25 Protein, His Tag (MALS verified)
HOT ILA-C52H8	Cynomolgus	HEK293	Cynomolgus IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (MALS verified)
ILA-H82F9	Human	HEK293	Biotinylated Human IL-2 R alpha / CD25 Protein, Fc,Avitag™ (MALS verified)
ILA-M82E9	Mouse	HEK293	Biotinylated Mouse IL-2 R alpha / CD25 Protein, His,Avitag™ (MALS verified)
ILA-C52H4	Canine	HEK293	Canine IL-2 R alpha / CD25 Protein, His Tag
ILA-C82E4	Cynomolgus	HEK293	Biotinylated Cynomolgus IL-2 R alpha / CD25 Protein, His,Avitag™ (MALS verified)
ILA-R52H3	Rhesus macaque	HEK293	Rhesus macaque IL-2 R alpha / CD25 Protein, His Tag (MALS verified)

총 수량11

IL-2 R alpha분자 별명

IL2RA,CD25,p55,IL2-RA,IL-2-RA

항체 프로젝트 거래 플랫폼

프로젝트 이름	프로젝트 단계	분자 유형	분자 출처	질병 영역	적응증
CD25 mAb - 01	PCC	Monoclonal	Humanized Mouse	Solid Tumor	Solid tumor

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Basiliximab biobetter (Mabtech/Sorrento)	STI-003	Phase 3 Clinical	Taizhou Maibo Taike Biotechnology Co Ltd	Autoimmune Diseases	상세
LMB-2	LMB-2; LMB-2a	Phase 2 Clinical	National Cancer Institute	Leukemia; Leukemia, Hairy Cell; Leukemia, T-Cell; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases; Myeloproliferative Disorders; Skin Melanoma; Skin Neoplasms	상세
Nemvaleukin alfa	RDB-1419; RDB-1450; ALKS-4230	Phase 2 Clinical	Alkermes Plc	Fallopian Tube Neoplasms; Melanoma; Ovarian Neoplasms; Peritoneal Neoplasms; Skin Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck	상세
Camidanlumab tesirine	ADCT-301	Phase 2 Clinical	Adc Therapeutics Sa, Genmab A/S	Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Esophageal Neoplasms; Fallopian Tube Neoplasms; Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Melanoma; Myelodysplastic Syndromes; Myeloproliferative Disorders; Ovarian Neoplasms; Pancreatic Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms	상세
90Y-HAT (NCI)		Phase 2 Clinical	National Cancer Institute	Hodgkin Disease; Lymphoma, Non-Hodgkin	상세
Humanized Anti-CD25 Antibody(Institute of Hematology & Blood Diseases Hospital)		Phase 2 Clinical	Institute Of Hematology & Blood Diseases Hospital	Graft vs Host Disease	상세
90Y Basiliximab		Phase 2 Clinical	City Of Hope National Medical Center	Hodgkin Disease; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Lymphoma, T-Cell, Cutaneous; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	상세
PT-101	PT-101; MK-6194; PT101	Phase 1 Clinical	Pandion Therapeutics	Colitis, Ulcerative; Dermatitis, Atopic; Lupus Erythematosus, Systemic; Vitiligo	상세
Anti-interleukin-2 receptor monoclonal antibody Mikbeta1	HuMikβ1-1	Phase 1 Clinical	F. Hoffmann-La Roche Ltd, National Institutes Of Health	Celiac Disease; Leukemia; Leukemia, Large Granular Lymphocytic; Leukemia, Lymphoid; Paraparesis, Tropical Spastic	상세
BA-1106	TS-1904; BA-1106; RR-102	Phase 1 Clinical	Shandong Boan Biotechnology Co Ltd	Solid tumours	상세
XmAb-564	XmAb-564; XmAb564; XmAb-27564	Phase 1 Clinical	Xencor Inc	Autoimmune Diseases; Dermatitis, Atopic; Psoriasis	상세
PF-08046032	PF-08046032	Phase 1 Clinical	Pfizer Inc	Carcinoma, Non-Small-Cell Lung; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell, Peripheral; Melanoma; Neoplasms; Squamous Cell Carcinoma of Head and Neck	상세
IL2 CD25 fusion protein (Bristol-Myers Squibb)		Phase 1 Clinical	University Of Miami	Autoimmune Diseases	상세
9MW-3911	9MW3911; 9MW-3911	Phase 1 Clinical	Nanjing Nuo Aixin Biotechnology Co Ltd	Neoplasms	상세
In 111-DOTA-Basiliximab		Phase 1 Clinical	City Of Hope National Medical Center	Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma	상세
BMS-986326	BMS-986326	Phase 1 Clinical	Bristol-Myers Squibb Company	Dermatitis, Atopic; Lupus Vulgaris	상세

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Daclizumab biosimilar (Shanghai CP Guojian)		Approved	Sunshine GuoJian Pharmaceutical (Shanghai) Co Ltd	健尼哌	Mainland China	Rejection of renal transplantation	null	2011-01-12	Rejection of renal transplantation	상세
Daclizumab	R-35; BIIB-019; RO-247375	Approved	Abbvie Inc, Biogen Inc, F. Hoffmann-La Roche Ltd	Zinbryta, Zenapax	United States	Rejection of organ transplantation	F. Hoffmann-La Roche Ag	1997-12-10	Anemia, Aplastic; Anemia, Diamond-Blackfan; Arthritis, Juvenile; Asthma; Behcet Syndrome; Breast Neoplasms; Carcinoma, Ductal; Colitis, Ulcerative; Diabetes Mellitus, Type 1; Gastrointestinal Diseases; Granulomatosis with Polyangiitis; HIV Infections; HTLV-I Infections; Inflammatory Bowel Diseases; Iritis; Leukemia; Leukemia, T-Cell; Lymphoma; Melanoma; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Myelodysplastic Syndromes; Psoriasis; Radiation Injuries; Red-Cell Aplasia, Pure; Rejection in heart transplantation; Rejection of organ transplantation; Retinal Diseases; Thrombocytopenia; Uveitis; Uveitis, Anterior	상세
Basiliximab	CHT-25; chRFT5; CHI-621; SDZ-CHI-621	Approved	Novartis Pharma Ag	舒莱, Simulect	United States	Rejection of organ transplantation	Novartis Pharma Ag	1998-05-12	Anemia, Aplastic; Colitis, Ulcerative; Coronavirus Disease 2019 (COVID-19); Cytokine Release Syndrome; Emphysema; Hemoglobinuria, Paroxysmal; Hodgkin Disease; Keratoplasty rejection; Kidney Failure, Chronic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Multiple Myeloma; Myelodysplastic Syndromes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Myelofibrosis; Pulmonary Disease, Chronic Obstructive; Rejection of renal transplantation; Rejection of organ transplantation; Uveitis	상세

제품 리뷰

E***n2023-04-08
1사람들이 좋아합니다
Human IL-2 R alpha / CD25 Protein, His Tag, low endotoxin (MALS verified)
Yeast cells expressing and displaying different IL2 variants were incubated 1h in the presence of CD25 protein with His tag (Human Il-2 R alpha Acrobiosystems #ILA-H52H9) at a final concentration of 4µg/ml. Next, cells were washed and incubated with a mouse Anti-His-PE. The yeast cells were washed and were analyzed using FACS. We observed detectable amounts of fluorescence bound to yeast cells displaying specific IL2 variants confirming that CD25 could bind to certain constructs and providing evidence that certain IL2 variants were correctly folded.
1***22022-08-03
0사람들이 좋아합니다
Mouse IL-2 R alpha / CD25 Protein, His Tag (MALS verified)
I purchased the company’s mouse-derived CD25 protein for the evaluation of CD25 antibody affinity. It achieved a high sensitivity detection with a small amount! Very satisfied, will come back to purchase more if needed!